Detalhe da pesquisa
1.
IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling.
Blood
; 134(23): 2092-2106, 2019 12 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31578204
2.
Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade.
Blood
; 132(16): 1675-1688, 2018 10 18.
Artigo
Inglês
| MEDLINE | ID: mdl-30154111
3.
Granulocytes Are Unresponsive to IL-6 Due to an Absence of gp130.
J Immunol
; 200(10): 3547-3555, 2018 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29626088
4.
The cationic small molecule GW4869 is cytotoxic to high phosphatidylserine-expressing myeloma cells.
Br J Haematol
; 177(3): 423-440, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28211573
5.
Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.
Cell Mol Life Sci
; 73(8): 1569-89, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26801219
6.
Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation.
Apoptosis
; 21(12): 1422-1437, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27734217
7.
Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10.
J Immunol
; 192(7): 3180-9, 2014 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24585878
8.
FLT3-ligand treatment of humanized mice results in the generation of large numbers of CD141+ and CD1c+ dendritic cells in vivo.
J Immunol
; 192(4): 1982-9, 2014 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24453245
9.
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.
Lancet Oncol
; 15(13): 1451-1459, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25456364
10.
Myeloma-induced alloreactive T cells arising in myeloma-infiltrated bones include double-positive CD8+CD4+ T cells: evidence from myeloma-bearing mouse model.
J Immunol
; 187(8): 3987-96, 2011 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21908738
11.
Depletion of exhausted alloreactive T cells enables targeting of stem-like memory T cells to generate tumor-specific immunity.
Sci Immunol
; 7(76): eabo3420, 2022 10 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36240285
12.
Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells.
Immunology
; 132(2): 296-305, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21091907
13.
Correction: Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma.
Oncotarget
; 12(9): 948-949, 2021 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33953848
14.
Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma.
Front Immunol
; 12: 620596, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33708212
15.
Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients.
Blood Adv
; 4(19): 4593-4604, 2020 10 13.
Artigo
Inglês
| MEDLINE | ID: mdl-32986791
16.
ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the Inflammasome.
Cancer Immunol Res
; 8(8): 1085-1098, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32444423
17.
Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells.
Exp Hematol
; 36(11): 1496-506, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18715688
18.
Mass Cytometry Discovers Two Discrete Subsets of CD39-Treg Which Discriminate MGUS From Multiple Myeloma.
Front Immunol
; 10: 1596, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31428081
19.
Bone marrow transplantation generates T cell-dependent control of myeloma in mice.
J Clin Invest
; 129(1): 106-121, 2019 01 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30300141
20.
Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model.
JCI Insight
; 52019 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31194697